Longeveron Inc (OQ:LGVN)

Business Focus: Biotechnology & Medical Research

Latest 10 SEC filings (by transaction date) for LGVN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 17th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 11/24 Jun 9/24 Baluch Khoso Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -125 $1.06
Jun 7/24 Jun 3/24 Lehr Paul T Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -325 $1.04
May 14/24 May 14/24 Kender Richard N Direct Ownership Class A Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
May 14/24 May 10/24 Kender Richard N Direct Ownership Class A Common Stock A - Grant, award or other under Rule 16b-3(d) 16,000 $1.46
May 6/24 May 2/24 Locklear Lisa Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -410 $2.83
May 6/24 May 2/24 Agafonova Nataliya Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -308 $2.83
Apr 12/24 Apr 11/24 Hare Joshua Direct Ownership Warrant (right to buy) P - Open market or private purchase 42,553 $0.125
Apr 12/24 Apr 11/24 Hare Joshua Direct Ownership Class A Common Stock P - Open market or private purchase 42,553 $2.35
Apr 12/24 Apr 11/24 Hashad Mohamed Wa'el Ahmed Direct Ownership Warrant (right to buy) P - Open market or private purchase 10,638 $0.125
Apr 12/24 Apr 11/24 Hashad Mohamed Wa'el Ahmed Direct Ownership Class A Common Stock P - Open market or private purchase 10,638 $2.35
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for LGVN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 17th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 11/24 Jun 9/24 Baluch Khoso Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -125 $1.06
Jun 7/24 Jun 3/24 Lehr Paul T Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -325 $1.04
May 14/24 May 10/24 Kender Richard N Direct Ownership Class A Common Stock A - Grant, award or other under Rule 16b-3(d) 16,000 $1.46
May 14/24 May 14/24 Kender Richard N Direct Ownership Class A Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
May 6/24 May 2/24 Locklear Lisa Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -410 $2.83
May 6/24 May 2/24 Agafonova Nataliya Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -308 $2.83
Apr 12/24 Apr 11/24 Hare Joshua Direct Ownership Warrant (right to buy) P - Open market or private purchase 42,553 $0.125
Apr 12/24 Apr 10/24 Hare Joshua Direct Ownership Warrant (right to buy) P - Open market or private purchase 106,383 $0.125
Apr 12/24 Apr 11/24 Hare Joshua Direct Ownership Class A Common Stock P - Open market or private purchase 42,553 $2.35
Apr 12/24 Apr 10/24 Hare Joshua Direct Ownership Class A Common Stock P - Open market or private purchase 106,383 $2.35
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $LGVN

  • No tweets found

Competitors

Competitors with Recent Insider Filings
Medpace Holdings (OQ:MEDP)
United Therapeutics (OQ:UTHR)
Janux Therapeutics (OQ:JANX)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.